Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study
When does viral load testing add value in sub-Saharan Africa?
PEPFAR funding linked to lower death rate from all causes in Africa
Tenofovir rectal microbicide safe; may have direct effect on tissues as well as virus
A new patient zero? Researchers may have spotted animal-to-human immunodeficiency virus transfer
Lipoatrophy common in children receiving d4T in South Africa
Keeping mothers in care: the real-world challenge for PMTCT programmes
Lopinavir/ritonavir cuts malaria risk in children with HIV
GS-7977 plus ribavirin rapidly suppresses HCV but most patients relapse
Telaprevir and boceprevir boost sustained response rates for HIV/HCV coinfected
Hormonal contraception and HIV risk in women: more evidence but uncertainty remains
Once-a-month HIV drug maintains good levels for prevention; few side-effects so far
Four doses of PrEP a week may be enough to protect
A tale of two trials: how adherence is everything in PrEP
